Arcus Biosciences, Inc. — Director's Dealing 2020

Dec 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-12-16

Reporting Person: Grossman William (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-16	Common Stock	S	2117	$31.35	Disposed	6727	Direct

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.

F2: Includes 992 shares purchased on 5/29/2020 and 1,002 shares purchased on 11/30/2020 through the Company's Employee Stock Purchase Plan.